Retraction Note: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer? (Prostate Cancer and Prostatic Diseases, (2008), 10.1038/pcan.2008.31)
Publication
, Journal Article
Mayes, JM; Mouraviev, V; Sun, L; Madden, JF; Polascik, TJ
Published in: Prostate Cancer and Prostatic Diseases
January 1, 2020
The authors hereby retract the e-publication dated 13 May 2008 and entitled, 'Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?' The authors are submitting a revised version with the same title. This article's statistics were performed for predicting bilateral prostate cancer outcomes. The article was written to help predict unilateral prostate cancer. Although the statistical numbers are correct, they are backwards. We apologize that the statistics indicate a contrary outcome (eg predicting bilateral cancer instead of unilateral disease).
Duke Scholars
Published In
Prostate Cancer and Prostatic Diseases
DOI
EISSN
1476-5608
ISSN
1365-7852
Publication Date
January 1, 2020
Related Subject Headings
- Urology & Nephrology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Mayes, J. M., Mouraviev, V., Sun, L., Madden, J. F., & Polascik, T. J. (2020). Retraction Note: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer? (Prostate Cancer and Prostatic Diseases, (2008), 10.1038/pcan.2008.31). Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/pcan.2008.31z
Published In
Prostate Cancer and Prostatic Diseases
DOI
EISSN
1476-5608
ISSN
1365-7852
Publication Date
January 1, 2020
Related Subject Headings
- Urology & Nephrology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis